The European Commission (EC) has approved Praluent (alirocumab) – a cholesterol-busing treatment from Sanofi and Regeneron Pharmaceuticals, Inc. The approval makes Praluent the first EC approved PCSK9 (proprotein convertase subtilisin/kexin type 9)…
Tag: Sanofi
Google, Sanofi to jointly take on diabetes
Google Life Sciences and Sanofi have joined hands to take on the menace of diabetes and to improve care and outcomes of people suffering from the disease. Google will be bringing in…
Sanofi inks deal with Evotec and Apeiron Biologics for immuno-oncology therapies
Sanofi has inked a deal with Evotec and Apeiron Biologics for carrying out research and development of first-in-class small molecule-based immuno-oncology therapies to treat solid and hematological cancers. The research collaboration and…